Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2012

01-04-2012 | Original Research

Effect of a Physician Uncertainty Reduction Intervention on Blood Pressure in Uncontrolled Hypertensives—A Cluster Randomized Trial

Authors: David J. Hyman, MD, Valory N. Pavlik, PhD, Anthony J. Greisinger, PhD, Wenyaw Chan, PhD, Jose Bayona, MD, Carol Mansyur, PhD, Victor Simms, MD, James Pool, MD

Published in: Journal of General Internal Medicine | Issue 4/2012

Login to get access

Abstract

BACKGROUND

Clinical inertia, provider failure to appropriately intensify treatment, is a major contributor to uncontrolled blood pressure (BP). Some clinical inertia may result from physician uncertainty over the patient’s usual BP, adherence, or value of continuing efforts to control BP through lifestyle changes.

OBJECTIVE

To test the hypothesis that providing physicians with uncertainty reduction tools, including 24-h ambulatory BP monitoring, electronic bottle cap monitoring, and lifestyle assessment and counseling, will lead to improved BP control.

DESIGN

Cluster randomized trial with five intervention clinics (IC) and five usual care clinics (UCC).

SETTING

Six public and 4 private primary care clinics.

PARTICIPANTS

A total of 665 patients (63 percent African American) with uncontrolled hypertension (BP ≥140 mmHg/90 mmHg or ≥130/80 mmHg if diabetic).

INTERVENTIONS

An order form for uncertainty reduction tools was placed in the IC participants’ charts before each visit and results fed back to the provider.

OUTCOME MEASURES

Percent with controlled BP at last visit. Secondary outcome was BP changes from baseline.

RESULTS

Median follow-up time was 24 months. IC physicians intensified treatment in 81% of IC patients compared to 67% in UCC (p < 0.001); 35.0% of IC patients and 31.9% of UCC patients achieved control at the last recorded visit (p > 0.05). Multi-level mixed effects longitudinal regression modeling of SBP and DBP indicated a significant, non-linear slope difference favoring IC (p time × group interaction = 0.048 for SBP and p = 0.001 for DBP). The model-predicted difference attributable to intervention was −2.8 mmHg for both SBP and DBP by month 24, and −6.5 mmHg for both SBP and DBP by month 36.

CONCLUSIONS

The uncertainty reduction intervention did not achieve the pre-specified dichotomous outcome, but led to lower measured BP in IC patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–50.PubMedCrossRef Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):2043–50.PubMedCrossRef
2.
go back to reference Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289(19):2560–71.PubMedCrossRef Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289(19):2560–71.PubMedCrossRef
3.
go back to reference Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7):479–86.PubMedCrossRef Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7):479–86.PubMedCrossRef
4.
go back to reference Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens. 2004;22(10):1849–55.PubMedCrossRef Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens. 2004;22(10):1849–55.PubMedCrossRef
5.
go back to reference Berlowitz D, Ash A, Hickey R, Friedman R, Glickman M, Kader B, Moskowitz M. Inadequate Management of Blood Pressure in a Hypertensive Population. N Engl J Med. 1998;339:1957–63.PubMedCrossRef Berlowitz D, Ash A, Hickey R, Friedman R, Glickman M, Kader B, Moskowitz M. Inadequate Management of Blood Pressure in a Hypertensive Population. N Engl J Med. 1998;339:1957–63.PubMedCrossRef
6.
go back to reference Rose AJ, Berlowitz DR, Orner MB, Kressin NR. Understanding uncontrolled hypertension: is it the patient or the provider? J Clin Hypertens (Greenwich). 2007;9(12):937–43.CrossRef Rose AJ, Berlowitz DR, Orner MB, Kressin NR. Understanding uncontrolled hypertension: is it the patient or the provider? J Clin Hypertens (Greenwich). 2007;9(12):937–43.CrossRef
7.
go back to reference Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–34.PubMed Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–34.PubMed
8.
go back to reference O'Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med. 2003;163(22):2677–8.PubMedCrossRef O'Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med. 2003;163(22):2677–8.PubMedCrossRef
9.
go back to reference Rose AJ, Shimada SL, Rothendler JA, et al. The accuracy of clinician perceptions of "usual" blood pressure control. J Gen Intern Med. 2008;23(2):180–3.PubMedCrossRef Rose AJ, Shimada SL, Rothendler JA, et al. The accuracy of clinician perceptions of "usual" blood pressure control. J Gen Intern Med. 2008;23(2):180–3.PubMedCrossRef
10.
go back to reference Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148(10):717–27.PubMed Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148(10):717–27.PubMed
11.
go back to reference Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160(15):2281–6.PubMedCrossRef Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160(15):2281–6.PubMedCrossRef
12.
go back to reference Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010;3(2):181–7.PubMedCrossRef Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010;3(2):181–7.PubMedCrossRef
13.
go back to reference Cummings DM, Doherty L, Howard G, et al. Blood pressure control in diabetes: temporal progress yet persistent racial disparities: national results from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study. Diabetes Care. 2010;33(4):798–803.PubMedCrossRef Cummings DM, Doherty L, Howard G, et al. Blood pressure control in diabetes: temporal progress yet persistent racial disparities: national results from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study. Diabetes Care. 2010;33(4):798–803.PubMedCrossRef
14.
go back to reference Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–27.PubMedCrossRef Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–27.PubMedCrossRef
15.
go back to reference Umscheid CA, Gross R, Weiner MG, Hollenbeak CS, Tang SS, Turner BJ. Racial disparities in hypertension control, but not treatment intensification. Am J Hypertens. 2010;23(1):54–61.PubMedCrossRef Umscheid CA, Gross R, Weiner MG, Hollenbeak CS, Tang SS, Turner BJ. Racial disparities in hypertension control, but not treatment intensification. Am J Hypertens. 2010;23(1):54–61.PubMedCrossRef
16.
go back to reference Manze M, Rose AJ, Orner MB, Berlowitz DR, Kressin NR. Understanding racial disparities in treatment intensification for hypertension management. J Gen Intern Med. 2010;25(8):819–25.PubMedCrossRef Manze M, Rose AJ, Orner MB, Berlowitz DR, Kressin NR. Understanding racial disparities in treatment intensification for hypertension management. J Gen Intern Med. 2010;25(8):819–25.PubMedCrossRef
17.
go back to reference Pavlik V, Greisinger A, Pool J, Haidet P, Hyman D. Does reducing physician uncertainty improve hypertension control: Rationale and Methods. Circ Cardiovasc Qual Outcomes. 2009;2:257–63.PubMedCrossRef Pavlik V, Greisinger A, Pool J, Haidet P, Hyman D. Does reducing physician uncertainty improve hypertension control: Rationale and Methods. Circ Cardiovasc Qual Outcomes. 2009;2:257–63.PubMedCrossRef
18.
go back to reference Block G, Gillespie C, Rosenbaum EH, Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med. 2000;18(4):284–8.PubMedCrossRef Block G, Gillespie C, Rosenbaum EH, Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med. 2000;18(4):284–8.PubMedCrossRef
19.
go back to reference Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMedCrossRef Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMedCrossRef
20.
go back to reference Hyman DJ, Pavlik VN, Taylor WC, Goodrick GK, Moye L. Simultaneous vs sequential counseling for multiple behavior change. Arch Intern Med. 2007;167(11):1152–8.PubMedCrossRef Hyman DJ, Pavlik VN, Taylor WC, Goodrick GK, Moye L. Simultaneous vs sequential counseling for multiple behavior change. Arch Intern Med. 2007;167(11):1152–8.PubMedCrossRef
21.
go back to reference Appel LJ, Giles TD, Black HR, et al. ASH position paper: dietary approaches to lower blood pressure. J Am Soc Hypertens. 2010;4(2):79–89.PubMedCrossRef Appel LJ, Giles TD, Black HR, et al. ASH position paper: dietary approaches to lower blood pressure. J Am Soc Hypertens. 2010;4(2):79–89.PubMedCrossRef
22.
go back to reference Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. New York, NY: Oxford University Press; 2000. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. New York, NY: Oxford University Press; 2000.
23.
go back to reference Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons, Inc.; 2004. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. Hoboken, NJ: John Wiley & Sons, Inc.; 2004.
24.
go back to reference Rabe-Hesketh S, Skrondal A. Multilevel and Longitudinal Modeling Using Stata. College Station, TX: Stata Press; 2008. Rabe-Hesketh S, Skrondal A. Multilevel and Longitudinal Modeling Using Stata. College Station, TX: Stata Press; 2008.
25.
go back to reference Viera AJ, Schmid D, Bostrom S, Yow A, Lawrence W, DuBard CA. Level of blood pressure above goal and clinical inertia in a Medicaid population. J Am Soc Hypertens. 2010;4(5):244–54.PubMedCrossRef Viera AJ, Schmid D, Bostrom S, Yow A, Lawrence W, DuBard CA. Level of blood pressure above goal and clinical inertia in a Medicaid population. J Am Soc Hypertens. 2010;4(5):244–54.PubMedCrossRef
26.
go back to reference Appel LJ, Wright JT Jr, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(10):918–29.PubMedCrossRef Appel LJ, Wright JT Jr, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(10):918–29.PubMedCrossRef
27.
go back to reference Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85.PubMedCrossRef Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85.PubMedCrossRef
28.
go back to reference Group JS. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115–27.CrossRef Group JS. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115–27.CrossRef
29.
go back to reference Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169(19):1748–55.PubMedCrossRef Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169(19):1748–55.PubMedCrossRef
30.
go back to reference Naik AD, Rodriguez E, Rao R, Teinert D, Abraham NS, Kalavar J. Quality improvement initiative for rapid induction of hypertension control in primary care. Circ Cardiovasc Qual Outcomes. 2010;3(5):558–64.PubMedCrossRef Naik AD, Rodriguez E, Rao R, Teinert D, Abraham NS, Kalavar J. Quality improvement initiative for rapid induction of hypertension control in primary care. Circ Cardiovasc Qual Outcomes. 2010;3(5):558–64.PubMedCrossRef
Metadata
Title
Effect of a Physician Uncertainty Reduction Intervention on Blood Pressure in Uncontrolled Hypertensives—A Cluster Randomized Trial
Authors
David J. Hyman, MD
Valory N. Pavlik, PhD
Anthony J. Greisinger, PhD
Wenyaw Chan, PhD
Jose Bayona, MD
Carol Mansyur, PhD
Victor Simms, MD
James Pool, MD
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/2012
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1888-1

Other articles of this Issue 4/2012

Journal of General Internal Medicine 4/2012 Go to the issue

Healing Arts: Materia Medica

A Prescription for Song

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.